Early-stage medical device developer International Biomedical Devices said yesterday it closed a $2 million seed funding round, with funds slated to support product development and pre-clinical studies.
Funds for the seed round of financing came from SCRA Technology Ventures’ SC Launch program, angel investors and management, IBMD said.
“This round of funding will enable us to finalize development of a commercial-ready system and complete certain preclinical tests toward regulatory review of our lead product, the ApertureRx Precision capsulotomy system. We are excited about our ability to continue innovation on this new device, which we feel will be important for assisting ophthalmic surgeons in creating a perfect capsulotomy, every time, during cataract surgery,” CEO Steven Bryant said in a press release.
IBMD’s flagship product, the ApertureRx precision capsulotomy system, is designed to create precise incisions during cateract surgeries, according to the Mount Pleasant, S.C.-based company.
The company said its non-laser based device is being designed to increase the safety of cataract surgery and create more predictable vision outcomes for patients by simplifying the current manual procedure.
The post Int’l Biomedical Devices closes $2m funding round appeared first on MassDevice.
from MassDevice http://ift.tt/1UFfCo1
Cap comentari:
Publica un comentari a l'entrada